Curigliano Giuseppe

Associate Professor
SSD
MED/06 - MEDICAL ONCOLOGY
Competition sector
06/D3 - BLOOD DISEASES, ONCOLOGY AND RHEUMATOLOGY
Vocational Master Coordinator
Master in Artificial Intelligence and Machine Learning in Cancer Medicine - secondo livello (MA8)

Contacts

Workplace

Via Ripamonti, 435 - IEO - Istituto Europeo di Oncologia
20141 MILANO (MI)

University email address
Teaching - Programme courses

Postgraduate programmes

A.Y. 2021/2022
2nd level vocational master
A.Y. 2020/2021
Advanced course
2nd level vocational master
A.Y. 2019/2020
Advanced course
2nd level vocational master
Postgraduate Schools - Medicine, Healthcare, Dental Medicine
A.Y. 2018/2019
Postgraduate Schools - Medicine, Healthcare, Dental Medicine
Research

Publications

Publications
  • Antibody–drug conjugates in solid tumors: a look into novel targets / C. Criscitiello, S. Morganti, G. Curigliano. - In: JOURNAL OF HEMATOLOGY & ONCOLOGY. - ISSN 1756-8722. - 14:1(2021 Dec).
  • Assessing Population Diversity in Phase III Trials of Cancer Drugs Supporting FDA Approval in Solid Tumors / E. Yekedüz, D. Trapani, W. Xu, E.G. de Vries, C. Labaki, B. Gyawali, S. Gulati, C. Nabhan, G. Utkan, G. Curigliano, T.K. Choueiri, Y. Ürün. - In: INTERNATIONAL JOURNAL OF CANCER. - ISSN 0020-7136. - 149:7(2021 Oct), pp. 1455-1462. [10.1002/ijc.33708]
  • Alpelisib in combination with everolimus ± exemestane in solid tumours : Phase Ib randomised, open-label, multicentre study / G. Curigliano, M. Martin, K. Jhaveri, J.T. Beck, G. Tortora, N. Fazio, M. Maur, R.A. Hubner, H. Lahner, V. Donnet, O. Ajipa, Z. Li, L. Blumenstein, F. Andre. - In: EUROPEAN JOURNAL OF CANCER. - ISSN 0959-8049. - 151(2021 Jul), pp. 49-62.
  • Phase I/Ib clinical trial of Sabatolimab, an Anti-TIM-3 Antibody, Alone and in Combination With Spartalizumab, an Anti-PD-1 Antibody, in Advanced Solid Tumors / G. Curigliano, H. Gelderblom, N. Mach, T. Doi, W.M. Tai, P.M. Forde, J. Sarantopoulos, P.L. Bedard, C. Lin, F.S. Hodi, S. Wilgenhof, A. Santoro, C. Sabatos-Peyton, T.A. Longmire, A. Xyrafas, H. Sun, S. Gutzwiller, L. Manenti, A. Naing. - In: CLINICAL CANCER RESEARCH. - ISSN 1078-0432. - (2021). [Epub ahead of print] [10.1158/1078-0432.CCR-20-4746]
  • Antibody–drug conjugates for the treatment of breast cancer / C. Corti, F. Giugliano, E. Nicolo, L. Ascione, G. Curigliano. - In: CANCERS. - ISSN 2072-6694. - 13:12(2021 Jun 09), pp. 2898.1-2898.23. [10.3390/cancers13122898]